Skip to content
Subscriber Only

Sophie’s Choice for Oncologists: Who Gets New Life-Saving Drug

  • First CAR-T therapy soon approved, but production roadblocks
  • Some dying patients won’t get it in time: ‘God, it’s awful’
Updated on

It’s a choice no doctor ever wants to make: which patient will get a chance to live, and which will not.

That is a decision oncologists may soon confront when the first two products in a revolutionary new way to treat cancer reach the U.S. market this year.